Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

WuXi AppTec’s new biomanufacturing facility is its third facility in the Philadelphia, PA Navy Yard.

WuXi AppTec Unveils Manufacturing Center for Cell and Gene Therapies

Gretchen L. Shearer, PhD, is a senior research chemist at McCrone Associates and an instructor at Hooke College of Applied Sciences, Westmont, IL. gshearer@mccrone.com.

Multiple inspection techniques facilitate the identification of particulate matter in vials as part of root-cause investigations and safety evaluations.

Looking for a Root Cause of Parenteral Contaminants

The Intelligent Control Inhaler is an intuitive, fully-integrated device delivering accurate doses of medication to patients, while providing on-screen instructions for use and feedback to the patient and healthcare provider via an app.

3M’s Intelligent Inhaler Wins Excellence in Drug Delivery Devices Award at CPhI

Novasep’s BioSC Lab chromatography is a flexible equipment that enables operations from one column up to six columns in batch, parallel batch, or continuous processing with all media and membrane types.

Novasep Named Bioprocessing Winner at the CPhI Pharma Awards

The winning entry was Merck’s Emprove program, which facilitates risk assessment and supplier qualification by providing instant, online access to regulatory and technical information on hundreds of products used in pharmaceutical and biopharmaceutical manufacturing.

Merck KGaA Named Winner of the Regulatory Procedures and Compliance Category for the CPhI Pharma Awards

Xellia added laboratory space and personnel in Zagreb, Croatia to work on anti-infective products that combat the antimicrobial resistance problem.

Xellia Pharmaceuticals Expands R&D in Croatia

The Koolit Advanced PCM Gel from Cold Chain Technologies provides cold-temperature protection for drugs and vaccines during transport.

Solid Phase-Change Material Provides Safe Cold Chain Shipment

A PESU membrane is now available for Sartorius Stedim Biotech Sartocon benchtop and production-scale filtration assemblies.

Integrated Membrane for Single-Use Filtration Assemblies Saves Set-Up and Validation Time

The hospital received a five-year $5 million grant from CDC to survey for communicable diseases in children and evaluate vaccine effectiveness.

Children’s Hospital of Pittsburgh of UPMC Receives Grant to Join Vaccine Surveillance Network

David W. Osborne, PhD, is Chief Scientific Officer and Founder, Independent Derm Solutions, LLC, 4215 Creekside Court, Fort Collins, CO 80525.

This article will equip the excipient vendor with an understanding of QbD from the perspective of the topical pharmaceutical product manufacturer.